The Pharmacokinetics of Dulcolax Essay

Exclusively available on Available only on IvyPanda® Made by Human No AI

Introduction

Dulcolax is provided by Boehringer Ingelheim Pharmaceuticals Inc. It consists of bisacodyl, which is a laxative that is locally acting. It is derived from the diphenylmethane derivatives group and possesses dual action.

Discussion

As such, its pharmacodynamics begins with bisacodyl stimulating after hydrolysis within the large intestine. The mucosa of the large intestine that is stimulated leads to colonic peristalsis in accordance with the accumulation of water (MIMS, n.d.). Further, electrolytes are also accumulated in the colonic lumen. Stimulation of defecation occurs and transit time is reduced while the stool is softened. When the rectum is stimulated, motility and rectal fullness sensation are increased. Essentially, the natural evacuation process is triggered within the lower area of the gastrointestinal tract.

The pharmacokinetics of the laxative occur through the administration of oral or rectal orifices. Bisacodyl becomes hydrolyzed rapidly to an active principle primarily through the enteric mucosa. The highest concentration of BHPM plasma was found to be through the administration of the enteric-coated tablet. Suppositories are able to provide results in 20 minutes post-administration but the maximum levels of BHPM-plasma concentration were reached between 0.5 and 3 hours after administration. The BHPM is able to provide results locally in the lower intestines because bisacodyl-coated tablets of the laxative can resist gastric juices. As such, the main drug release occurs in the colon.

Conclusion

Patients should be aware of the special precautions when taking Dulcolax. This includes the avoidance of daily intake of the laxative or its use over extended periods of time. Prolonged use of the laxative can lead to electrolyte imbalance and hypokalaemia (EMC, n.d.). Similarly, there is the potential for dehydration which can lead to oliguria and thirst, which can be especially dangerous for patients experiencing intestinal fluid loss.

References

EMC. (n.d.). . EMC. Web.

MIMS. (n.d.). . MIMS. Web.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2024, January 21). The Pharmacokinetics of Dulcolax. https://ivypanda.com/essays/the-pharmacokinetics-of-dulcolax/

Work Cited

"The Pharmacokinetics of Dulcolax." IvyPanda, 21 Jan. 2024, ivypanda.com/essays/the-pharmacokinetics-of-dulcolax/.

References

IvyPanda. (2024) 'The Pharmacokinetics of Dulcolax'. 21 January.

References

IvyPanda. 2024. "The Pharmacokinetics of Dulcolax." January 21, 2024. https://ivypanda.com/essays/the-pharmacokinetics-of-dulcolax/.

1. IvyPanda. "The Pharmacokinetics of Dulcolax." January 21, 2024. https://ivypanda.com/essays/the-pharmacokinetics-of-dulcolax/.


Bibliography


IvyPanda. "The Pharmacokinetics of Dulcolax." January 21, 2024. https://ivypanda.com/essays/the-pharmacokinetics-of-dulcolax/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
1 / 1